ESTRO Multidisciplinary Management of Breast Cancer 2017

Less local treatment: conclusions

• We know what we know – and that comes from the past  we have to cope with that

• Comparative data on toxicity and QoL of RT vs adjuvant hormonal treatment are lacking

• Our “feelings” on risks and treatment benefits probably need to be adapted

• What’s new tomorrow will be challenged again ~ possibly outdated after tomorrow